Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ozurdex in Suboptimal Diabetic Macular Edema
NCT04856397Unknown
- Sponsor
- Uptown Eye Specialists
- Start
- May 2021
- Primary completion
- Aug 2021
- Modality
- Implantable Devices, Implantable Hydrogels, Small Molecules
01
Overview
Randomised, open-label trial of ozurdex in diabetic macular edema (DME) (4 arms), sponsored by Uptown Eye Specialists. Primary endpoint: Visual acuity at 1 year. Status: unknown.
02
Drugs
ozurdex
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT04856397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04856397.